Trial intelligence / Profile preview

IV Artesunate Dosing in Children with Severe Malaria

NCT00522132Phase 2Completed

Sponsor
Medicines for Malaria Venture
Start
Sep 2007
Primary completion
Jun 2008
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of artesunate in malaria, sponsored by Medicines for Malaria Venture. Started Sep 2007; status: completed.

02

Drugs

artesunate
03

Conditions

malaria

Beyond the preview

Go deeper on NCT00522132.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00522132.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call